Business

Grapefruit USA, Inc. Announces Execution of New License Agreement with Zylö Therapeutics Inc. Expanding Grapefruit’s Patented Hourglass Product line to include Hemp-Derived CBD Topical Delivery Creams For Nationwide Distribution

Grapefruit USA, Inc. Announces Execution of New License Agreement with Zylö Therapeutics Inc. Expanding Grapefruit’s Patented Hourglass Product line to include Hemp-Derived CBD Topical Delivery Creams For Nationwide Distribution.

articleGrapefruit Usa Inc.December 9, 20204/company/grapefruit-usa-inc/news/grapefruit-usa-inc-announces-execution-of-new-license-agreement-with-zylo-therapeutics-inc-expanding-grapefruits-patented-hourglass-product-line-to-include-hemp-derived-cbd-topical-delivery-creams-for-nationwide-distribution
Grapefruit USA, Inc. Announces Execution of New License Agreement with Zylö Therapeutics Inc. Expanding Grapefruit’s Patented Hourglass Product line to include   Hemp-Derived CBD Topical Delivery Creams For Nationwide Distribution

About this update from Grapefruit Usa Inc.

[{"type":"text","content":"Powered by Zylö's patented Xerogel Silica Gel ("Z-Pod™") delivery system, Grapefruit's Patented Hourglass™ THC + Cannabinoid Topical Cream is the world's first and only known meaningfully effective THC+Cannabinoid-loaded transdermal cream that penetrates the five layers of human skin breaking through the dermal pathway to penetrate the human blood-brain barrier thereby successfully delivering beneficial cannabinoids throughout the human bloodstream and body in a predictable, steady dose over a targeted time period.The new Grapefruit/Zylo Agreement grants Grapefruit the right to produce Hemp-derived CBD, Farm Bill of 2018 compliant, versions of Hourglass by Grapefruit™ Topical Delivery Cream. Grapefruit customers who desire to enjoy the benefits of truly effective, time release non-THC CBD products for whatever reason may now do so by using Hourglass by Grapefruit™ CBD products. No other CBD products on Earth offer this advantage.The new license agreement grants Grapefruit exclusive rights to Zylö's patented time-release Z-Pod™ technology for THC+Cannabinoid Topical Cream in the United States, Canada, and Mexico and non-exclusive rights to produce and sell Hemp-derived CBD products utilizing the Z-Pod™ technology through licensed retail outlets in California and through E-commerce Nationwide.The unique architecture of Grapefruit's Hourglass™ time-release delivery cream provides Grapefruit with the ability to formulate endless variations of its Hourglass™ product line for both medical and recreational users ranging from purely THC recreational products in recreationally legal jurisdictions like California and Illinois to THC/CBD blends where legal to purely CBD products which are legal throughout the United States and many other countries.Grapefruit will commence retail sales of Hourglass by Grapefruit™ this week.LOS ANGELES and DESERT HOT SPRINGS, CA / ACCESSWIRE / December 9, 2020 / Grapefruit USA, Inc. (OTCQB:GPFT) ("Grapefruit" or the "Company"), a fully licensed California-based cannabis company, announced today that on December 2, 2020 it entered into a new License Agreement and Exclusive Supply Agreement with Zylö Therapeutics Inc. of Greenville, S.C. Execution of this agreement marks expansion of the use o...

More updates from Grapefruit Usa Inc.